Munich, Germany, April 27th, 2012 - Genomatix is proud to announce that it has been awarded the "INDUSTRIEPREIS 2012" in the biotech category at Hannover Messe, the world's biggest technology trade show. The INDUSTRIEPREIS is awarded in 14 categories to companies for products of a high technological, economic, ecological or social value. Nominees and winners are chosen by a panel of 30 experts including professors and specialized journalists. Genomatix has received the INDUSTRIEPREIS for its data analysis and interpretation platform Genomatix Genome Analyzer (GGA).
"We're really proud to have received this award for a data analysis solution", says Dr. Korbinian Grote, product manager at Genomatix. "Usually the focus on big technology fairs is more on lab equipment providers, in our field the sequencer manufacturers stand out with ever new records of gigabases of DNA data they can produce. But researchers also need solutions to analyze and interpret these data to extract the information from it and generate new biomedical knowledge." "Being appreciated for our data analysis solutions is certainly a big motivation for the whole team to come up with even more innovative ideas on how to deal with the increasing deluge of Next Generation Sequencing data", adds Dr. Martin Seifert, CEO of Genomatix, "getting an award that explicitly rewards products of technological and social value underlines that NGS is quickly moving from a research tool into the broader field of clinical application."
The INDUSTRIEPREIS has been created in 2006 by Huber Verlag für Neue Medien GmbH. It is awarded to companies showing high technological, economical, ecological or social value. It is awarded for a distinct solution or product, which each company needs to present in the application. An independent jury of 30 professionals (including professors and specialized journalists) evaluates the applications and selects category and overall winners.
For more information please visit www.industriepreis.de
Genomatix Software GmbH is one of the world's leading suppliers of technologies to analyze and interpret genomic data. Headquartered in Munich (Germany), Genomatix has a global presence by representations in Ann Arbor, MI (USA), Paris (France), London (UK) and Tokyo (Japan). Founded in 1997, Genomatix pioneered the analysis and understanding of eukaryotic gene regulation. More than a decade of developments in computational and systems biology has put Genomatix into the position to have all needed data content and a complete analysis pipeline in place at the arrival of next generation sequencing technology. Genomatix has published more than 120 peer reviewed scientific papers with more than 5,000 citations. Over 35,000 researchers worldwide currently apply Genomatix tools and databases.
For further information, please visit http://www.genomatix.de
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.